Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 11156397)

1.

Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.

Goel A, Colcher D, Baranowska-Kortylewicz J, Augustine S, Booth BJ, Pavlinkova G, Batra SK.

Cancer Res. 2000 Dec 15;60(24):6964-71.

2.

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK.

Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. Epub 2004 Oct 2.

PMID:
15791435
3.

Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.

Goel A, Beresford GW, Colcher D, Pavlinkova G, Booth BJ, Baranowska-Kortylewicz J, Batra SK.

J Biochem. 2000 May;127(5):829-36.

4.

99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.

Goel A, Baranowska-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ, Batra SK.

J Nucl Med. 2001 Oct;42(10):1519-27.

5.

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.

Pavlinkova G, Beresford GW, Booth BJ, Batra SK, Colcher D.

J Nucl Med. 1999 Sep;40(9):1536-46.

6.

Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.

Pavlinkova G, Colcher D, Booth BJ, Goel A, Batra SK.

Cancer Immunol Immunother. 2000 Jul;49(4-5):267-75.

PMID:
10941910
7.

Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.

Goel A, Augustine S, Baranowska-Kortylewicz J, Colcher D, Booth BJ, Pavlinkova G, Tempero M, Batra SK.

Clin Cancer Res. 2001 Jan;7(1):175-84.

8.

Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody.

Beresford GW, Pavlinkova G, Booth BJ, Batra SK, Colcher D.

Int J Cancer. 1999 Jun 11;81(6):911-7.

PMID:
10362138
9.

99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody .

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Jun 26 [updated 2007 Dec 28].

10.

Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49.

Wittel UA, Jain M, Goel A, Baranowska-Kortylewicz J, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK.

Biochem Biophys Res Commun. 2005 Apr 1;329(1):168-76.

PMID:
15721289
11.

Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.

Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.

Cancer Res. 1991 Dec 1;51(23 Pt 1):6363-71.

12.

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK.

Nucl Med Biol. 2005 Feb;32(2):157-64.

PMID:
15721761
13.

Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Jul 23 [updated 2008 Jan 22].

14.

Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.

Pavlinkova G, Booth BJ, Batra SK, Colcher D.

Clin Cancer Res. 1999 Sep;5(9):2613-9.

15.

99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody .

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Jun 19 [updated 2008 Jan 28].

16.

Radioiodinated-antiā€“TAG-72 covalently linked CC49 divalent single-chain Fv antibody.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Sep 25 [updated 2007 Oct 30].

17.

Single-chain antibodies in pancreatic cancer.

Colcher D, Pavlinkova G, Beresford G, Booth BJ, Batra SK.

Ann N Y Acad Sci. 1999 Jun 30;880:263-80. Review.

PMID:
10415872
18.

Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.

Kashmiri SV, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH.

Hybridoma. 1995 Oct;14(5):461-73.

PMID:
8575795
19.

Constructs of biotin mimetic peptide with CC49 single-chain Fv designed for tumor pretargeting.

Pavlinkova G, Batra SK, Colcher D, Booth BJ, Baranowska-Kortylewicz J.

Peptides. 2003 Mar;24(3):353-62.

PMID:
12732332
20.

Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.

Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.

Cancer Res. 1993 Aug 15;53(16):3776-83. Erratum in: Cancer Res 1993 Dec 1;53(23):5832.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk